Vertex Pharmaceuticals (Germany) Top Insiders
VX1 Stock | EUR 375.00 9.50 2.47% |
Vertex Pharmaceuticals employs about 4.8 K people. The company is managed by 9 executives with a total tenure of roughly 11200 years, averaging almost 1244.0 years of service per executive, having 533.33 employees per reported executive. Examination of Vertex Pharmaceuticals' management performance can provide insight into the company performance.
Jeffrey MD Insider Ex Chairman |
Ourania Tatsis Insider Ex Officer |
Vertex |
Vertex Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of 0.1733 % which means that it generated a profit of $0.1733 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2767 %, meaning that it generated $0.2767 on every $100 dollars invested by stockholders. Vertex Pharmaceuticals' management efficiency ratios could be used to measure how well Vertex Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Vertex Pharmaceuticals Workforce Comparison
Vertex Pharmaceuticals Incorporated is rated below average in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 314,911. Vertex Pharmaceuticals claims roughly 4,800 in number of employees contributing just under 2% to stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.37 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.49 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.49. Vertex Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Vertex Pharmaceuticals Price Series Summation is a cross summation of Vertex Pharmaceuticals price series and its benchmark/peer.
Vertex Pharmaceuticals Notable Stakeholders
A Vertex Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Vertex Pharmaceuticals often face trade-offs trying to please all of them. Vertex Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Vertex Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jeffrey MD | Ex Chairman | Profile | |
Ourania Tatsis | Ex Officer | Profile | |
MD FASN | Pres CEO | Profile | |
Susie Lisa | VP Relations | Profile | |
Stuart BSc | Ex COO | Profile | |
Mike Tirozzi | SVP Officer | Profile | |
Damian Esq | Chief VP | Profile | |
Charles Wagner | Ex CFO | Profile | |
Kristen Ambrose | Tax, Accounting | Profile |
About Vertex Pharmaceuticals Management Performance
The success or failure of an entity such as Vertex Pharmaceuticals often depends on how effective the management is. Vertex Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Vertex management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Vertex management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company was founded in 1989 and is headquartered in Boston, Massachusetts. VERTEX PHARMAC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2500 people.
Vertex Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Vertex Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Vertex Pharmaceuticals within its industry.Vertex Pharmaceuticals Manpower Efficiency
Return on Vertex Pharmaceuticals Manpower
Revenue Per Employee | 1.9M | |
Revenue Per Executive | 992.3M | |
Net Income Per Employee | 692.1K | |
Net Income Per Executive | 369.1M |
Complementary Tools for Vertex Stock analysis
When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
CEOs Directory Screen CEOs from public companies around the world |